Buys
Open market- Shares
- +14,124
- Avg price
- $17.89
- Total value
- +$252,678
Timothy John Garnett - Director at MapLight Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer symbol
- MPLT on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
Past-year transaction volume for Timothy John Garnett in MapLight Therapeutics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +14,124
- Share %
- 100%
- Total value
- +$252,678
Reported holdings for Timothy John Garnett in MapLight Therapeutics, Inc.
Form 4 holding
Director
MapLight Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 49,525
- Estimated value
- $944,441
- Report date
- 10 Feb 2026
- Price
- $19.07
- Ownership
- Direct
Form 4 holding
Director
MapLight Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 14,124
- Estimated value
- $252,678
- Report date
- 10 Feb 2026
- Price
- $17.89
- Ownership
- Indirect
Form 4 holding
Director
MapLight Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 25,604
- Estimated value
- Report date
- 27 Oct 2025
- Price
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
Transaction history for Timothy John Garnett in MapLight Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.